EU lawmaker likens AstraZeneca to ‘unreliable second-hand car salesman’ as low European jab confidence hampers vaccine uptake
Doses of the Oxford-AstraZeneca Covid-19 vaccine are going unused across the EU amid low confidence in the jab after the company was repeatedly criticized by Brussels for not sharing sufficient data and supply problems.
Speaking on Thursday, EU lawmaker Esther de Lange, a vice president of the European People’s party, reiterated the challenge of getting “reliable data” from AstraZeneca.
AstraZeneca is behaving like an unreliable second-hand car salesman. Getting reliable data from this company is still a challenge.
Such criticism of the jab by public figures in Europe has been commonplace in recent months. French President Emmanuel Macron suggested the vaccine was “quasi-ineffective,” and it wasn’t given approval for the over 65s, the most-at-risk demographic, in France and Germany despite a WHO (World Health Organization) recommendation.
Read more: EU lawmaker likens AstraZeneca to ‘unreliable second-hand car salesman’ as low European jab confidence hampers vaccine uptake